Unicycive Therapeutics, Inc.
UNCY
$6.93
-$0.19-2.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.67M | -6.01M | -6.45M | 570.00K | -21.53M |
| Total Depreciation and Amortization | 151.00K | 148.00K | 138.00K | 135.00K | 134.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.55M | -337.00K | 197.00K | -7.79M | 13.14M |
| Change in Net Operating Assets | -2.06M | 237.00K | -2.31M | -1.82M | 1.70M |
| Cash from Operations | -8.03M | -5.96M | -8.42M | -8.90M | -6.55M |
| Capital Expenditure | 0.00 | -2.00K | -6.00K | -16.00K | -22.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.07M | -- | -- | -- | -- |
| Cash from Investing | -12.07M | -2.00K | -6.00K | -16.00K | -22.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.81M | 27.15M | 11.33M | 2.79M | 683.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 0.00 |
| Other Financing Activities | -205.00K | -815.00K | -346.00K | -244.00K | -318.00K |
| Cash from Financing | 6.61M | 26.33M | 10.98M | 2.55M | 365.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.50M | 20.37M | 2.56M | -6.37M | -6.21M |